Analysis of Runx1 Using Induced Gene Ablation Reveals Its Essential Role in 
Pre-liver HSC Development and Limitations of an In Vivo Approach.

Senserrich, Jordi; Batsivari, Antoniana; Rybtsov, Stanislav; Gordon-Keylock, Sabrina; Souilhol, Celine; Buchholz, Frank; Hills, David; Zhao, Suling; Medvinsky, Alexander

doi:10.1016/j.stemcr.2018.08.004

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Analysis of Runx1 Using Induced Gene Ablation Reveals Its Essential Role in Pre-liver HSC Development and Limitations of an In Vivo Approach.

MPS-Authors

/persons/resource/persons219042

Buchholz, Frank
Max Planck Institute for Molecular Cell Biology and Genetics, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Senserrich, J., Batsivari, A., Rybtsov, S., Gordon-Keylock, S., Souilhol, C., Buchholz, F., Hills, D., Zhao, S., & Medvinsky, A. (2018). Analysis of Runx1 Using Induced Gene Ablation Reveals Its Essential Role in Pre-liver HSC Development and Limitations of an In Vivo Approach. Stem cell reports, 11(3), 784-794. doi:10.1016/j.stemcr.2018.08.004.

引用: https://hdl.handle.net/21.11116/0000-0003-F680-6

要旨

Hematopoietic stem cells (HSCs) develop in the embryonic aorta-gonad-mesonephros (AGM) region and subsequently relocate to fetal liver. Runx1 transcription factor is essential for HSC development, but is largely dispensable for adult HSCs. Here, we studied tamoxifen-inducible Runx1 inactivation in vivo. Induction at pre-liver stages (up to embryonic day 10.5) reduced erythromyeloid progenitor numbers, but surprisingly did not block the appearance of Runx1-null HSCs in liver. By contrast, ex vivo analysis showed an absolute Runx1 dependency of HSC development in the AGM region. We found that, contrary to current beliefs, significant Cre-inducing tamoxifen activity persists in mouse blood for at least 72 hr after injection. This deferred recombination can hit healthy HSCs, which escaped early Runx1 ablation and result in appearance of Runx1-null HSCs in liver. Such extended recombination activity in vivo is a potential source of misinterpretation, particularly in analysis of dynamic developmental processes during embryogenesis.